Literature DB >> 23224254

[Chronic pelvic pain syndrome: neurostimulation, neuromodulation and acupuncture].

M Walter1, U Sammer, T M Kessler.   

Abstract

Chronic pelvic pain syndrome (CPPS) is defined by the European Association of Urology guidelines as a non-malignant pain perceived in structures related to the pelvis of either women or men for at least 6 months without proven infection or other obvious pathology. It affects the quality of life of millions of people worldwide and has an impact similar to that reported for other chronic diseases, such as diabetes mellitus, Crohn's disease and congestive heart failure. The treatment of CPPS remains a challenge despite several established first line therapies because many patients are therapy refractory. Unconventional treatments, such as neurostimulation, neuromodulation and acupuncture may be highly successful for treating CPPS and have a favorable adverse event profile. Thus, these promising therapeutic alternatives should be considered more often in daily clinical practice.

Entities:  

Mesh:

Year:  2012        PMID: 23224254     DOI: 10.1007/s00120-012-3037-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  60 in total

1.  Surgery Illustrated – surgical atlas sacral neuromodulation.

Authors:  Jens Wöllner; Christian Hampel; Thomas M Kessler
Journal:  BJU Int       Date:  2012-07       Impact factor: 5.588

Review 2.  Alternative therapies for the treatment of chronic prostatitis.

Authors:  Lara K Suh; Franklin C Lowe
Journal:  Curr Urol Rep       Date:  2011-08       Impact factor: 3.092

3.  Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study.

Authors:  Craig V Comiter
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

Review 4.  Stimulation methods for neuropathic pain control.

Authors:  M P Stojanovic
Journal:  Curr Pain Headache Rep       Date:  2001-04

5.  A prospective randomized trial comparing the 1-stage with the 2-stage implantation of a pulse generator in patients with pelvic floor dysfunction selected for sacral nerve stimulation.

Authors:  K Everaert; W Kerckhaert; H Caluwaerts; M Audenaert; H Vereecke; G De Cuypere; A Boelaert; U Van den Hombergh; W Oosterlinck
Journal:  Eur Urol       Date:  2004-05       Impact factor: 20.096

6.  A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis.

Authors:  Kenneth M Peters; Kevin M Feber; Richard C Bennett
Journal:  BJU Int       Date:  2007-10       Impact factor: 5.588

7.  Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three-arm randomized trial.

Authors:  Sang-Hun Lee; Byung-Cheol Lee
Journal:  Urology       Date:  2009-05       Impact factor: 2.649

8.  Percutaneous tibial nerve stimulation as neuromodulative treatment of chronic pelvic pain.

Authors:  Michael R van Balken; Vera Vandoninck; Bert J Messelink; Henk Vergunst; John P F A Heesakkers; Frans M J Debruyne; Bart L H Bemelmans
Journal:  Eur Urol       Date:  2003-02       Impact factor: 20.096

9.  Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo-control randomized trial.

Authors:  Lamina Sikiru; Hanif Shmaila; Samani A Muhammed
Journal:  Int Braz J Urol       Date:  2008 Nov-Dec       Impact factor: 1.541

10.  Unilateral versus bilateral stage I neuromodulator lead placement for the treatment of refractory voiding dysfunction.

Authors:  Khanh Pham; Michael L Guralnick; R Corey O'Connor
Journal:  Neurourol Urodyn       Date:  2008       Impact factor: 2.696

View more
  2 in total

1.  [Auricular acupuncture in patients with detrusor overactivity: a pilot study].

Authors:  T Bschleipfer; G Lüdecke; M Durschnabel; F M E Wagenlehner; W Weidner; A Pilatz
Journal:  Urologe A       Date:  2014-11       Impact factor: 0.639

Review 2.  Neuromodulation in Chronic Pelvic Pain: A Narrative Review.

Authors:  Hao Xiang; Tingting Zhang; Abdullah Al-Danakh; Deyong Yang; Lina Wang
Journal:  Pain Ther       Date:  2022-07-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.